Fig. 2
From: Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer’s disease
Group comparisons of blood-based markers between APOE ε4 carriers (39 M/27F) and non-ε4 carriers (34 M/35F) across all participants after adjusting for age, sex, and education. When the analysis was carried out with stratified amyloid status or clinical diagnosis, the difference was no longer observed for all three markers